- Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells
YUKIE YOSHII et al, 2016 CrossRef - Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance
David J. Monsma et al, 2014, Pediatr Blood Cancer CrossRef - In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells
Judith Niesen et al, 2015, J Cancer Res Clin Oncol CrossRef - null
Stephan Lindsey et al, 2015 CrossRef - Targeting protein kinases to reverse multidrug resistance in sarcoma
Hua Chen et al, 2016, Cancer Treatment Reviews CrossRef - Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
Maximilian M. L. Knott et al, 2020, Cancer Metastasis Rev CrossRef - Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors
Kristy Pilbeam et al, 2018, Oncotarget CrossRef - Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma
Anke E.M. van Erp et al, 2018, Mol Cancer Ther CrossRef - HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
Carla De Giovanni et al, 2021, Cells CrossRef - Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance
Elena Poli et al, 2021, OncoImmunology CrossRef - Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
Wen-I Chang et al, 2022, Front. Pharmacol. CrossRef - Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef